Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by Felcoon Jun 12, 2014 11:59am

257 Views

Post# 22653768

RE:4050 phase 1

Hi Bepando,

Did I miss something or miss hear comments regarding timing on phase 1 results. Already well behind expected time lines, I thought Dr. Moran indicated the final two subjects would finish phase 1 trials by mid June and we could expect the release of results by the end of June. Can anyone else confirm?

Thanks,
Felco

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments